A detailed history of Colonial Trust Advisors transactions in Haleon PLC stock. As of the latest transaction made, Colonial Trust Advisors holds 719 shares of HLN stock, worth $6,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
719
Previous 1,519 52.67%
Holding current value
$6,974
Previous $12,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$8.32 - $10.7 $6,656 - $8,560
-800 Reduced 52.67%
719 $7,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $9,053 - $12,243
1,519 New
1,519 $12,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.